{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:01Z","timestamp":1792787821877,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82072004"],"award-info":[{"award-number":["82072004"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02545-3","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:16:31Z","timestamp":1783350991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of pathological complete response to neoadjuvant therapy in breast cancer integrating intratumoral and peritumoral delta radiomics with clinical features: a study based on multiparametric MRI"],"prefix":"10.1186","volume":"26","author":[{"given":"Xin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"2545_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2545_CR2","first-page":"12","volume":"33","author":"Committee of Breast Cancer Society CA-CA, Breast Cancer Study Group CSoCMA","year":"2023","unstructured":"Committee of Breast Cancer Society CA-CA, Breast Cancer Study Group CSoCMA. Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition). China Oncol. 2023;33:12.","journal-title":"China Oncol"},{"key":"2545_CR3","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","volume":"32","author":"HJ Burstein","year":"2021","unstructured":"Burstein HJ, Curigliano G, Thurlimann B, Weber WP, Poortmans P, Regan MM, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32:1216\u201335.","journal-title":"Ann Oncol"},{"key":"2545_CR4","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/cancers13102447","volume":"13","author":"RW Granzier","year":"2021","unstructured":"Granzier RW, Ibrahim A, Primakov SP, Samiei S, van Nijnatten TJ, de Boer M, et al. MRI-based radiomics analysis for the pretreatment prediction of pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients: a multicenter study. Cancers. 2021;13:2447.","journal-title":"Cancers"},{"key":"2545_CR5","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.2147\/DDDT.S253961","volume":"14","author":"H Wang","year":"2020","unstructured":"Wang H, Mao X. Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer. Drug Des Devel Ther. 2020;14:2423\u201333.","journal-title":"Drug Des Devel Ther"},{"key":"2545_CR6","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","volume":"30","author":"G Von Minckwitz","year":"2012","unstructured":"Von Minckwitz G, Untch M, Blohmer J-U, Costa SD, Eidtmann H, Fasching PA, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30:1796\u2013804.","journal-title":"J Clin Oncol"},{"key":"2545_CR7","doi-asserted-by":"crossref","unstructured":"Reig B, Heacock L, Lewin A, Cho N, Moy L. Role of MRI to assess response to neoadjuvant therapy for breast cancer. J Magn Reson Imaging. 2020;52.","DOI":"10.1002\/jmri.27145"},{"key":"2545_CR8","doi-asserted-by":"publisher","first-page":"1249339","DOI":"10.3389\/fonc.2023.1249339","volume":"13","author":"Y Yu","year":"2024","unstructured":"Yu Y, Wang Z, Wang Q, Su X, Li Z, Wang R, et al. Radiomic model based on magnetic resonance imaging for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Front Oncol. 2024;13:1249339.","journal-title":"Front Oncol"},{"key":"2545_CR9","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.acra.2023.10.051","volume":"31","author":"J-X Huang","year":"2024","unstructured":"Huang J-X, Wu L, Wang X-Y, Lin S-Y, Xu Y-F, Wei M-J, et al. Delta radiomics based on longitudinal dual-modal ultrasound can early predict response to neoadjuvant chemotherapy in breast cancer patients. Acad Radiol. 2024;31:1738\u201347.","journal-title":"Acad Radiol"},{"key":"2545_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clbc.2024.01.005","volume":"24","author":"J Han","year":"2024","unstructured":"Han J, Hua H, Fei J, Liu J, Guo Y, Ma W, et al. Prediction of disease-free survival in breast cancer using deep learning with ultrasound and mammography: a multicenter study. Clin Breast Cancer. 2024;24:215\u201326.","journal-title":"Clin Breast Cancer"},{"key":"2545_CR11","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1158\/1078-0432.CCR-18-3190","volume":"25","author":"Z Liu","year":"2019","unstructured":"Liu Z, Li Z, Qu J, Zhang R, Zhou X, Li L, et al. Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study. Clin Cancer Res. 2019;25:3538\u201347.","journal-title":"Clin Cancer Res"},{"key":"2545_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1007\/s11547-021-01436-7","volume":"126","author":"V Nardone","year":"2021","unstructured":"Nardone V, Reginelli A, Grassi R, Boldrini L, Vacca G, D\u2019Ippolito E, et al. Delta radiomics: a systematic review. Radiol Med. 2021;126:1571\u201383.","journal-title":"Radiol Med"},{"key":"2545_CR13","doi-asserted-by":"crossref","unstructured":"Guo L, Du S, Gao S, Zhao R, Huang G, Jin F, et al. Delta-radiomics based on dynamic contrast-enhanced MRI predicts pathologic complete response in breast cancer patients treated with neoadjuvant chemotherapy. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14143515"},{"key":"2545_CR14","doi-asserted-by":"publisher","first-page":"622219","DOI":"10.3389\/fmolb.2021.622219","volume":"8","author":"M Fan","year":"2021","unstructured":"Fan M, Chen H, You C, Liu L, Gu Y, Peng W, et al. Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer. Front Mol Biosci. 2021;8:622219.","journal-title":"Front Mol Biosci"},{"key":"2545_CR15","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.2214\/AJR.20.23255","volume":"216","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xia Y, Tolat PP, Long L, Jiang Z, Huang Z, et al. Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion. AJR Am J Roentgenol. 2021;216:1510\u201320.","journal-title":"AJR Am J Roentgenol"},{"key":"2545_CR16","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1007\/s00330-022-08539-3","volume":"32","author":"H Xu","year":"2022","unstructured":"Xu H, Liu J, Chen Z, Wang C, Liu Y, Wang M, et al. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer. Eur Radiol. 2022;32:4845\u201356.","journal-title":"Eur Radiol"},{"key":"2545_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13058-017-0846-1","volume":"19","author":"NM Braman","year":"2017","unstructured":"Braman NM, Etesami M, Prasanna P, Dubchuk C, Gilmore H, Tiwari P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19:57.","journal-title":"Breast Cancer Res"},{"key":"2545_CR18","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn H-J. Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736\u201347.","journal-title":"Ann Oncol"},{"key":"2545_CR19","unstructured":"Lundberg SM, Lee S-I. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst. 2017;30."},{"key":"2545_CR20","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/j.clbc.2023.05.010","volume":"23","author":"X Wang","year":"2023","unstructured":"Wang X, Hua H, Han J, Zhong X, Liu J, Chen J. Evaluation of multiparametric MRI radiomics-based nomogram in prediction of response to neoadjuvant chemotherapy in breast cancer: a two-center study. Clin Breast Cancer. 2023;23:e331\u201344.","journal-title":"Clin Breast Cancer"},{"key":"2545_CR21","doi-asserted-by":"publisher","first-page":"773581","DOI":"10.3389\/fimmu.2021.773581","volume":"12","author":"X Han","year":"2021","unstructured":"Han X, Cao W, Wu L, Liang C. Radiomics Assessment of the Tumor Immune Microenvironment to Predict Outcomes in Breast Cancer. Front Immunol. 2021;12:773581.","journal-title":"Front Immunol"},{"key":"2545_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00432-021-03822-0","volume":"148","author":"S Niu","year":"2022","unstructured":"Niu S, Jiang W, Zhao N, Jiang T, Dong Y, Luo Y, et al. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI. J Cancer Res Clin Oncol. 2022;148:97\u2013106.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2545_CR23","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/cancers17091520","volume":"17","author":"DH Jang","year":"2025","unstructured":"Jang DH, Kolios C, Osapoetra LO, Sannachi L, Curpen B, Pejovi\u0107-Mili\u0107 A, et al. Pre-treatment prediction of breast cancer response to neoadjuvant chemotherapy using intratumoral and peritumoral radiomics from T2-weighted and contrast-enhanced T1-weighted MRI. Cancers. 2025;17:1520.","journal-title":"Cancers"},{"key":"2545_CR24","doi-asserted-by":"publisher","first-page":"1556317","DOI":"10.3389\/fonc.2025.1556317","volume":"15","author":"H Zhang","year":"2025","unstructured":"Zhang H, Miao Q, Fu Y, Pan R, Jin Q, Gu C, et al. Intratumoral and peritumoral radiomics based on automated breast volume scanner for predicting human epidermal growth factor receptor 2 status. Front Oncol. 2025;15:1556317.","journal-title":"Front Oncol"},{"key":"2545_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12885-025-13678-z","volume":"25","author":"Q Zeng","year":"2025","unstructured":"Zeng Q, Deng Y, Nan J, Zou Z, Yu T, Liu L. Delta dual\u2013region DCE-MRI radiomics from breast masses predicts axillary lymph node response after neoadjuvant therapy for breast cancer. BMC Cancer. 2025;25:264.","journal-title":"BMC Cancer"},{"key":"2545_CR26","doi-asserted-by":"publisher","first-page":"1561599","DOI":"10.3389\/fonc.2025.1561599","volume":"15","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhang S, Wei W, Yang L, Wang L, Wang Y, et al. Intra-and peritumoral radiomics nomogram based on DCE-MRI for the early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer. Front Oncol. 2025;15:1561599.","journal-title":"Front Oncol"},{"key":"2545_CR27","doi-asserted-by":"crossref","unstructured":"Qi Y-J, Su G-H, You C, Zhang X, Xiao Y, Jiang Y-Z, et al. Radiomics in breast cancer: current advances and future directions. Cell Rep Med. 2024;5.","DOI":"10.1016\/j.xcrm.2024.101719"},{"key":"2545_CR28","unstructured":"Cromb\u00e9 A, Kataoka M. Breast cancer molecular subtype prediction: improving interpretability of complex machine-learning models based on multiparametric-MRI features using SHapley Additive exPlanations (SHAP) methodology. Diagn Interv Imaging. 2024:S2211\u20135684 (2224) 00033."},{"key":"2545_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/biof.1995","volume":"50","author":"CJ Ejiyi","year":"2024","unstructured":"Ejiyi CJ, Qin Z, Monday H, Ejiyi MB, Ukwuoma C, Ejiyi TU, et al. Breast cancer diagnosis and management guided by data augmentation, utilizing an integrated framework of SHAP and random augmentation. BioFactors. 2024;50:114\u201334.","journal-title":"BioFactors"},{"key":"2545_CR30","doi-asserted-by":"crossref","unstructured":"Yao Q, Du Y, Liu W, Liu X, Zhang M, Zha H, et al. Improving prediction accuracy of residual axillary lymph node metastases in node-positive triple-negative breast cancer: a radiomics analysis of ultrasound-guided clip locations using the SHAP method. Acad Radiol. 2024.","DOI":"10.1016\/j.acra.2024.10.039"},{"key":"2545_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12880-025-01553-z","volume":"25","author":"Y Lu","year":"2025","unstructured":"Lu Y, Jin L, Ding N, Li M, Yin S, Ji Y. The value of multiparametric MRI radiomics and machine learning in predicting preoperative Ki-67 expression level in breast cancer. BMC Med Imaging. 2025;25:11.","journal-title":"BMC Med Imaging"},{"key":"2545_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10549-013-2620-0","volume":"140","author":"EH Lips","year":"2013","unstructured":"Lips EH, Mulder L, de Ronde JJ, Mandjes IA, Koolen BB, Wessels LF, et al. Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response. Breast Cancer Res Treat. 2013;140:63\u201371.","journal-title":"Breast Cancer Res Treat"},{"key":"2545_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/RLI.0000000000000518","volume":"54","author":"A Tahmassebi","year":"2019","unstructured":"Tahmassebi A, Wengert GJ, Helbich TH, Bago-Horvath Z, Alaei S, Bartsch R, et al. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients. Invest Radiol. 2019;54:110\u20137.","journal-title":"Invest Radiol"},{"key":"2545_CR34","doi-asserted-by":"publisher","first-page":"955250","DOI":"10.3389\/fendo.2022.955250","volume":"13","author":"B Qian","year":"2022","unstructured":"Qian B, Yang J, Zhou J, Hu L, Zhang S, Ren M, et al. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study. Front Endocrinol (Lausanne). 2022;13:955250.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2545_CR35","doi-asserted-by":"publisher","first-page":"2413702","DOI":"10.1002\/advs.202413702","volume":"12","author":"YH Huang","year":"2025","unstructured":"Huang YH, Shi ZY, Zhu T, Zhou TH, Li Y, Li W, et al. Longitudinal MRI-Driven Multi\u2010Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer. Adv Sci. 2025;12:2413702.","journal-title":"Adv Sci"},{"key":"2545_CR36","doi-asserted-by":"crossref","unstructured":"Herrero Vicent C, Tudela X, Moreno Ruiz P, Pedralva V, Jimenez Pastor A, Ahicart D, et al. Machine learning models and multiparametric magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14143508"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02545-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:02:42Z","timestamp":1790892162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02545-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02545-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Boards of both participating institutions (Institution A: Medical Ethics Committee of the Affiliated Hospital of Qingdao University, approval No. QYFY WZLL 29981; Institution B: Medical Ethics Committee of the Affiliated Yantai Yuhuangding Hospital of Qingdao University, approval No. 2023\u2009\u2212\u2009352). The requirement for written informed consent was waived by the Institutional Review Boards due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"488"}}